tiprankstipranks
Advertisement
Advertisement
iRadimed backs FY26 EPS view $2.06-$2.21, consensus $2.08
PremiumThe FlyiRadimed backs FY26 EPS view $2.06-$2.21, consensus $2.08
2M ago
IRMD Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
IRMD Upcoming Earnings Report: What to Expect?
3M ago
iRadimed initiated with a Buy at Freedom Broker
Premium
The Fly
iRadimed initiated with a Buy at Freedom Broker
3M ago
Midday Fly By: Coca-Cola reports Q4 beat, BP suspends buyback
PremiumThe FlyMidday Fly By: Coca-Cola reports Q4 beat, BP suspends buyback
5M ago
iRadimed reports Q4 EPS 54c vs 44c last year
Premium
The Fly
iRadimed reports Q4 EPS 54c vs 44c last year
5M ago
iRadimed sees Q1 adjusted EPS 44c-48c
Premium
The Fly
iRadimed sees Q1 adjusted EPS 44c-48c
5M ago
iRadimed price target raised to $98 from $90 at Roth Capital
PremiumThe FlyiRadimed price target raised to $98 from $90 at Roth Capital
8M ago
Iradimed Corp Reports Record Q3 2025 Results
Premium
Company Announcements
Iradimed Corp Reports Record Q3 2025 Results
8M ago
iRadimed price target raised to $98 from $90 at Roth Capital
Premium
The Fly
iRadimed price target raised to $98 from $90 at Roth Capital
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100